Aspirin for the primary prevention of skin cancer: A meta-analysis

Oncology Letters

Volumn 9, Issue 3, 2015, Pages 1073-1080

  Zhu, Yun ^a   Cheng, Yang ^a   Luo, Rong Cheng ^a   Li, Ai Min ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Aspirin; Meta analysis; Primary prevention; Skin cancer

Indexed keywords

ACETYLSALICYLIC ACID;

ARTICLE; BASAL CELL CARCINOMA; CANCER RISK; DISEASE DURATION; HUMAN; MELANOMA; META ANALYSIS; OUTCOME ASSESSMENT; QUESTIONNAIRE; SCORING SYSTEM; SENSITIVITY ANALYSIS; SKIN CANCER; SKIN COLOR; SKIN PROTECTION; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; VITAMIN INTAKE;

EID: 84921822396     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2015.2853     Document Type: Article

References (39)

1. D'Orazio J, Jarrett S, Amaro-Ortiz A and Scott T: UV radiation and the skin. Int J Mol Sci 14: 12222-12248, 2013.
2. Marks R: An overview of skin cancers. Incidence and causation. Cancer 75: 607-612, 1995.
3. Chen ST, Geller AC and Tsao H: Update on the Epidemiology of Melanoma. Curr Dermatol Rep 2: 24-34, 2013.
4. MacKie RM, Hauschild A and Eggermont AM: Epidemiology of invasive cutaneous melanoma. Ann Oncol 20 Suppl 6: vi1-vi7, 2009.
5. Saladi RN and Persaud AN: The causes of skin cancer: a comprehensive review. Drugs Today (Barc) 41: 37-53, 2005.
6. Council on Environmental Health, Section on Dermatology; Balk SJ: Ultraviolet radiation: a hazard to children and adolescents. Pediatrics 127: 588-597, 2011.
7. Kornek T and Augustin M: Skin cancer prevention. J Dtsch Dermatol Ges 11: 283-296; quiz 297-298, 2013.
8. Buckman SY, Gresham A, Hale P, et al.: COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 19: 723-729, 1998.
9. Fosslien E: Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci 30: 3-21, 2000.
10. Denkert C, Köbel M, Berger S, et al: Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61: 303-308, 2001.
11. Nijsten T, Colpaert CG, Vermeulen PB, et al: Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases. Br J Dermatol 151: 837-845, 2004.
12. Rao CV and Reddy BS: NSAIDs and chemoprevention.Curr Cancer Drug Targets 4: 29-42, 2004.
13. Harris RE, Beebe-Donk J, Doss H and Burr Doss D: Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review). Oncol Rep 13: 559-583, 2005.
14. Silva MT, Galvao TF, Zimmerman IR, Pereira MG and Lopes LC: Non-aspirin non-steroidal anti-inflammatory drugs for the primary chemoprevention of non-gastrointestinal cancer: summary of evidence. Curr Pharm Des 18: 4047-4070, 2012.
15. Sneader W: The discovery of aspirin: a reappraisal. BMJ 321: 1591-1594, 2000.
16. Asgari MM, Chren MM, Warton EM, Friedman GD and White E: Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma. Arch Dermatol 146: 388-395, 2010.
17. Asgari MM, Maruti SS and White E: A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence. J Natl Cancer Inst 100: 967-971, 2008.
18. Cahoon EK, Rajaraman P, Alexander BH, Doody MM, Linet MS and Freedman DM: Use of nonsteroidal anti-inflammatory drugs and risk of basal cell carcinoma in the United States Radiologic Technologists study. Int J Cancer 130: 2939-2948, 2012.
19. Curiel-Lewandrowski C, Nijsten T, Gomez ML, Hollestein LM, Atkins MB and Stern RS: Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study. J Invest Dermatol 131: 1460-1468, 2011.
20. Gamba CA, Swetter SM, Stefanick ML, et al: Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative. Cancer 119: 1562-1569 2013.
21. Jacobs EJ, Thun MJ, Bain EB, Rodriguez C, Henley SJ and Calle EE: A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 99: 608-615, 2007.
22. Jeter JM, Bonner JD, Johnson TM and Gruber SB: Nonsteroidal anti-inflammatory drugs and risk of melanoma.J Skin Cancer 2011: 598571, 2011.
23. Jeter JM, Han J, Martinez ME, Alberts DS, Qureshi AA and Feskanich D: Non-steroidal anti-inflammatory drugs, acetaminophen, and risk of skin cancer in the Nurses' Health Study. Cancer Causes Control 23: 1451-1461, 2012.
24. Johannesdottir SA, Chang ET, Mehnert F, Schmidt M, Olesen AB and Sørensen HT: Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study. Cancer 118: 4768-4776, 2012.
25. Joosse A, Koomen ER, Casparie MK, Herings RM, Guchelaar HJ and Nijsten T: Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study. J Invest Dermatol 129: 2620-2627, 2009.
26. Torti DC, Christensen BC, Storm CA, et al: Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study. J Am Acad Dermatol 65: 304-312, 2011.
27. Wells GA, Shea B, O'Connell D, et al: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Department of Epidemiology and Community Medicine, University of Ottawa, Canada; http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed October 12, 2007.
28. Begg CB and Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101, 1994.
29. Egger M, Davey Smith G, Schneider M and Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634, 1997.
30. Higgins JP, Thompson SG, Deeks JJ and Altman DG: Measuring inconsistency in meta-analyses. BMJ 327: 557-560, 2003.
31. DerSimonian R and Laird N: Meta-analysis in clinical trials. Control Clin Trials 7: 177-188, 1986.
32. Christenson LJ, Borrowman TA, Vachon CM, et al: Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 294:681-690, 2005.
33. An KP, Athar M, Tang X, et al: Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches. Photochem Photobiol 76: 73-80, 2002.
34. Asgari M, White E and Chren MM: Nonsteroidal anti-inflammatory drug use in the prevention and treatment of squamous cell carcinoma. Dermatol Surg 30: 1335-1342, 2004.
35. Fürstenberger G, Marks F and Müller-Decker K: Cyclooxygenase-2 and skin carcinogenesis. Prog Exp Tumor Res 37: 72-89, 2003.
36. Cole BF, Logan RF, Halabi S, et al: Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 101: 256-266, 2009.
37. Bardia A, Olson JE, Vachon CM, et al: Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.Breast Cancer Res Treat 126: 149-155, 2011.
38. Zhang X, Smith-Warner SA, Collins LC, Rosner B, Willett WC and Hankinson SE: Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol 30: 3468-3477, 2012.
39. Burn J, Gerdes AM, Macrae F, et al; CAPP2 Investigators: Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 378: 2081-2087, 2011.